Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lucidyx is a precision medicine company that leverages advanced data analytics and multi-omic integration to transform drug development and patient care. The company's proprietary platform utilizes machine learning and bioinformatics to analyze complex biological datasets, identifying predictive biomarkers and optimizing clinical trial designs. By providing "Precision Medicine as a Service," Lucidyx helps biopharmaceutical partners match the right patients with the right therapies, thereby increasing the probability of clinical success. Their expertise spans across oncology, immunology, and rare diseases, focusing on bridging the gap between raw data and actionable clinical insights. Lucidyx aims to accelerate the delivery of personalized treatments through more efficient and targeted research and development processes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lucidyx.